Walvax Biotechnology Co., Ltd.

XSEC:300142 Stock Report

Market Cap: CN¥23.1b

Walvax Biotechnology Future Growth

Future criteria checks 3/6

Walvax Biotechnology is forecast to grow earnings and revenue by 54.6% and 11.7% per annum respectively. EPS is expected to grow by 54.4% per annum. Return on equity is forecast to be 6.1% in 3 years.

Key information

54.6%

Earnings growth rate

54.4%

EPS growth rate

Biotechs earnings growth43.4%
Revenue growth rate11.7%
Future return on equity6.1%
Analyst coverage

Low

Last updated29 Oct 2024

Recent future growth updates

No updates

Recent updates

Earnings and Revenue Growth Forecasts

XSEC:300142 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20263,961788N/A8512
12/31/20253,605646N/A1,0062
12/31/20243,114399N/A1,1782
9/30/20243,097122163832N/A
6/30/20243,37913552839N/A
3/31/20243,8802625855N/A
12/31/20234,1144191881,134N/A
9/30/20234,5387512141,191N/A
6/30/20234,9067631581,185N/A
3/31/20235,2648622181,395N/A
1/1/20235,0867291101,201N/A
9/30/20225,0405951601,311N/A
6/30/20224,461530-841,118N/A
3/31/20223,685434-263856N/A
1/1/20223,463428-398705N/A
9/30/20213,501932-660267N/A
6/30/20213,7151,261-525139N/A
3/31/20213,2601,053-45226N/A
12/31/20202,9391,003-293114N/A
9/30/20201,890457-275120N/A
6/30/20201,194119-30384N/A
3/31/20201,05785-34313N/A
12/31/20191,121142-29062N/A
9/30/20191,0981,444-24172N/A
6/30/20191,0001,426-327-44N/A
3/31/20199331,430-265-13N/A
12/31/20188741,415-293-65N/A
9/30/2018807-407-307-81N/A
6/30/2018786-421N/A-62N/A
3/31/2018700-484N/A-14N/A
12/31/2017668-537N/A-10N/A
9/30/2017628265N/A70N/A
6/30/2017555189N/A55N/A
3/31/201746683N/A-33N/A
12/31/201659170N/A-90N/A
9/30/2016692-963N/A-153N/A
6/30/2016885-936N/A-169N/A
3/31/20161,045-835N/A-133N/A
12/31/20151,006-841N/A-69N/A
9/30/2015843182N/A-44N/A
6/30/2015731138N/A-73N/A
3/31/2015705147N/A-16N/A
12/31/2014719143N/A-66N/A
9/30/2014816-139N/A-149N/A
6/30/2014750-91N/A-159N/A
3/31/2014676-29N/A-149N/A
12/31/201358348N/A-122N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 300142's forecast earnings growth (54.6% per year) is above the savings rate (2.8%).

Earnings vs Market: 300142's earnings (54.6% per year) are forecast to grow faster than the CN market (26.3% per year).

High Growth Earnings: 300142's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: 300142's revenue (11.7% per year) is forecast to grow slower than the CN market (13.9% per year).

High Growth Revenue: 300142's revenue (11.7% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 300142's Return on Equity is forecast to be low in 3 years time (6.1%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y